{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T20:19:17Z","timestamp":1770149957499,"version":"3.49.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Clonal plasma cell disorders, such as multiple myeloma (MM), often cause excretion of monoclonal free light chains (MFLC) into urine that serve as diagnostic markers and can cause renal injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Content<\/jats:title>\n                    <jats:p>Measures of urinary protein excretion (PEx) and MFLC excretion are parameters for diagnosing and managing plasma cell disorders, although the roles are evolving as new diagnostic tools are applied. Current guidelines dictate measuring PEx and MFLC excretion using 24-hour urine specimens, which have multiple shortcomings that compromise the quality of testing, delay results, and are burdensome for patients. These problems raise consideration of alternatives to the 24-hour PEx (24-hPEx). Such changes in practice have occurred for evaluating proteinuria in many other disorders. Calculating an estimated 24-hPEx based on urine protein\/creatinine ratios on spot specimens is one option that overcomes many shortcomings of the measured 24-hPEx. Random urine specimens also probably are preferable for qualitative testing (absence or presence of MFLC) for diagnostic applications and MM response monitoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Measurement of PEx and MFLC excretion using 24-hour collections is unreliable, inconvenient, and delays evaluation of plasma cell disorders. Estimated 24-hPEx based on protein assays of spot urine specimens overcomes many of these problems and should be evaluated by further studies. Changing routine practice requires guideline and protocol modification and action by laboratories to increase availability of testing and calculated values. Issues described here also have relevance to evaluating proteinuria in other disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jalm\/jfaf130","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T11:37:35Z","timestamp":1755603455000},"page":"1664-1674","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of Proteinuria in Plasma Cell Disorders: Shortcomings of Measurements Based on 24-Hour Collections and Alternative Approaches"],"prefix":"10.1093","volume":"10","author":[{"given":"Glen L","family":"Hortin","sequence":"first","affiliation":[{"name":"Department of Pathology, Moffitt Cancer Center , Tampa, FL ,","place":["United States"]},{"name":"Department of Oncologic Science, Morsani College of Medicine, University of South Florida , Tampa, FL ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M","family":"Koomen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Moffitt Cancer Center , Tampa, FL ,","place":["United States"]},{"name":"Department of Oncologic Science, Morsani College of Medicine, University of South Florida , Tampa, FL ,","place":["United States"]},{"name":"Molecular Oncology, Moffitt Cancer Center , Tampa, FL ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"2025110423204549600_jfaf130-B1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am J Hematol"},{"key":"2025110423204549600_jfaf130-B2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.clml.2024.03.008","article-title":"SOHO state of the art updates and next questions: diagnosis and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"24","author":"Schmidt","year":"2024","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2025110423204549600_jfaf130-B3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12882-024-03717-5","article-title":"Kidney function in newly diagnosed myeloma patients: factors associated with kidney impairment and recovery","volume":"35","author":"Cesar","year":"2024","journal-title":"BMC Nephrol"},{"key":"2025110423204549600_jfaf130-B4","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMra1810907","article-title":"Monoclonal gammopathy of renal significance","volume":"384","author":"Leung","year":"2021","journal-title":"N Engl J Med"},{"key":"2025110423204549600_jfaf130-B5","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol"},{"key":"2025110423204549600_jfaf130-B6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.annonc.2020.11.014","article-title":"Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Dimopoulos","year":"2021","journal-title":"Ann Oncol"},{"key":"2025110423204549600_jfaf130-B7","volume-title":"Electrophoresis and mass spectrometry: monoclonal gammopathies and protein disorders","author":"Keren","year":"2024"},{"key":"2025110423204549600_jfaf130-B8","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/clinchem\/hvae179","article-title":"Application of mass spectrometry proteomic methods to immunoglobulins in the clinical laboratory","volume":"70","author":"Murray","year":"2024","journal-title":"Clin Chem"},{"key":"2025110423204549600_jfaf130-B9","doi-asserted-by":"crossref","first-page":"100427","DOI":"10.1016\/j.xkme.2022.100427","article-title":"Correlation between 24-hour urine protein and random urine protein-creatinine ratio in amyloid light-chain amyloidosis","volume":"4","author":"Mendelson","year":"2022","journal-title":"Kidney Med"},{"key":"2025110423204549600_jfaf130-B10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1373\/clinchem.2008.117143","article-title":"Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine","volume":"55","author":"Palladini","year":"2009","journal-title":"Clin Chem"},{"key":"2025110423204549600_jfaf130-B11","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/clinchem\/hvad053","article-title":"Utilizing mas spectrometry to detect and isotype monoclonal proteins in urine: comparison to electrophoretic methods","volume":"69","author":"Moonen","year":"2023","journal-title":"Clin Chem"},{"issue":"Suppl 1","key":"2025110423204549600_jfaf130-B12","first-page":"i255","article-title":"Relation of free immunoglobulin light chain concentration to overflow proteinuria","volume":"70","author":"Hortin","year":"2024","journal-title":"Clin Chem"},{"key":"2025110423204549600_jfaf130-B13","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guidelines for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int"},{"key":"2025110423204549600_jfaf130-B14","first-page":"97102","article-title":"Laboratory measurement of urine albumin and urine total protein in screening for proteinuria in chronic kidney disease","volume":"32","author":"Martin","year":"2011","journal-title":"Clin Biochem Rev"},{"key":"2025110423204549600_jfaf130-B15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/10408363.2020.1723487","article-title":"Diagnostic utility of protein to creatinine ratio (P\/C ratio) in spot urine samples within routine clinical practice","volume":"57","author":"Kaminska","year":"2020","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2025110423204549600_jfaf130-B16","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.5858\/133.12.1954","article-title":"Strategies for improving the collection of 24-hour urine for analysis in the clinical laboratory. Redesigned instructions, opinion surveys, and application of reference change value to micturition","volume":"133","author":"Tormo","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"2025110423204549600_jfaf130-B17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4274\/ejgg.galenos.2021.2021-4-3","article-title":"The correlation between total protein level in 24-hour urine sample and spot urine protein-to-creatinine ration in the old aged","volume":"31","author":"Cengiz","year":"2021","journal-title":"Eur J Gerontol"},{"key":"2025110423204549600_jfaf130-B18","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/jch.13696","article-title":"Addressing the problem of inaccuracy of measured 24-hour urine collections due to incomplete collection","volume":"21","author":"Mann","year":"2019","journal-title":"J Clin Hypertens"},{"key":"2025110423204549600_jfaf130-B19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/clinchem\/33.2.297","article-title":"Proteinuria in health and disease assessed by measuring the urinary protein\/creatinine ratio","volume":"32","author":"Lemann","year":"1987","journal-title":"Clin Chem"},{"key":"2025110423204549600_jfaf130-B20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1158\/1055-9965.EPI-10-0069","article-title":"Urine collection and processing for protein biomarker discovery and quantification","volume":"19","author":"Thomas","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025110423204549600_jfaf130-B21","first-page":"679","article-title":"Mid-stream vs. first-voided urine collection by using automated analyzers for particle examination in healthy subjects: an Italian multicenter study","volume":"50","author":"Manoni","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"2025110423204549600_jfaf130-B22","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1515\/cclm-2024-0070","article-title":"The EFLM European Urinalysis Guideline 2023","volume":"62","author":"Kouri","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"2025110423204549600_jfaf130-B23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0009-8981(89)90024-7","article-title":"Stability of alpha 1 microglobulin, beta 2 microglobulin, and retinol binding protein in urine","volume":"179","author":"Donaldson","year":"1989","journal-title":"Clin Chim Acta"},{"key":"2025110423204549600_jfaf130-B24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/prca.200780082","article-title":"Discovery and validation of urinary biomarkers for prostate cancer","volume":"2","author":"Theodorescu","year":"2008","journal-title":"Proteomics Clin Appl"},{"key":"2025110423204549600_jfaf130-B25","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1515\/cclm-2013-0868","article-title":"The effect of centrifugation on three urine protein assays: benzethonium chloride, benzalkonium chloride and pyrogallol red","volume":"52","author":"Surer","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"2025110423204549600_jfaf130-B26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/cs0690395","article-title":"A circadian rhythm of proteinuria in patients with a nephrotic syndrome","volume":"69","author":"Koopman","year":"1985","journal-title":"Clin Sci (London)"},{"key":"2025110423204549600_jfaf130-B27","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJM198312223092503","article-title":"Use of single voided urine samples to estimate quantitative proteinuria","volume":"309","author":"Ginsberg","year":"1983","journal-title":"N Engl J Med"},{"key":"2025110423204549600_jfaf130-B28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.51219\/JMMS\/Hortin-GL\/02","article-title":"Urine protein\/creatinine ratio and urine protein excretion: a survey of reference ranges and test naming in laboratory directories","volume":"1","author":"Hortin","year":"2024","journal-title":"J M Med Stu"},{"key":"2025110423204549600_jfaf130-B29","doi-asserted-by":"crossref","first-page":"e2.1","DOI":"10.1053\/ajkd.2002.29920","article-title":"Electrophoretic pattern of concentrated urine: comparison between 24-hour collection and random samples","volume":"39","author":"Bottini","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"Suppl","key":"2025110423204549600_jfaf130-B30","first-page":"309","article-title":"Evaluation of spot urine protein to creatinine ratio and 24-hour urine protein quantification for proteinuria in patients with plasma cell dyscrasia","volume":"15","author":"Apuri","year":"2013","journal-title":"J Clin Oncol"},{"key":"2025110423204549600_jfaf130-B31","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/j.ajog.2024.07.046","article-title":"Performance comparison of 4 short methods for urine-protein estimation versus the standard 24-hour method for diagnosis of proteinuria: a prospective observational study","volume":"231","author":"Massalha","year":"2024","journal-title":"Am J Obstetr Gynecol"},{"key":"2025110423204549600_jfaf130-B32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000313448","article-title":"Estimation of daily proteinuria in patients with multiple myeloma by using the protein-to-creatinine ratio in random urine samples","volume":"123","author":"Wozney","year":"2010","journal-title":"Acta Haematol"},{"key":"2025110423204549600_jfaf130-B33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.clml.2025.01.003","article-title":"SPOT protein\/creatinine ratio as an alternative to 24-hour urine collection for measuring proteinuria in patients with multiple myeloma: a prospective study","volume":"25","author":"Jamshed","year":"2025","journal-title":"Clin Lymphoma Myelocma Leuk"},{"key":"2025110423204549600_jfaf130-B34","first-page":"5686","article-title":"Estimation of daily proteinuria in patients with amyloidosis by using the protein-to-creatinine ratio in random urine samples","volume":"7","author":"Talame","year":"2015","journal-title":"Rare Tumors"},{"key":"2025110423204549600_jfaf130-B35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2125.1983.tb01490.x","article-title":"The influence of a cooked meat meeal on creatinine plasma concentration and creatinine clearance","volume":"15","author":"Mayersohn","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"2025110423204549600_jfaf130-B36","doi-asserted-by":"crossref","first-page":"24043","DOI":"10.1002\/jcla.24043","article-title":"Reference values of urine protein\/creatinine ratio in healthy Dalian adults","volume":"35","author":"Liu","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"2025110423204549600_jfaf130-B37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12882-022-02673-2","article-title":"An equation to estimate 24-hour total urine protein excretion rate in patients who underwent urine protein testing","volume":"23","author":"Yan","year":"2022","journal-title":"BMC Nephrol"},{"key":"2025110423204549600_jfaf130-B38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.clinbiochem.2004.12.010","article-title":"Problems with the estimation of urine protein by automated assays","volume":"38","author":"Dube","year":"2005","journal-title":"Clin Biochem"},{"key":"2025110423204549600_jfaf130-B39","doi-asserted-by":"crossref","first-page":"e15813","DOI":"10.1111\/ped.15813","article-title":"Differences in urinary protein-to-creatinine ratio suing the benzethonium chloride and pyrogallol red methods in children","volume":"66","author":"Koide","year":"2024","journal-title":"Pediatr Int"},{"key":"2025110423204549600_jfaf130-B40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1182\/blood-2024-199615","article-title":"24-Hour urine testing does not add value to multiple myeloma response assessments: a secondary analysis of BMT CTN 0702","volume":"144","author":"Banerjee","year":"2024","journal-title":"Blood"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/10\/6\/1664\/64236972\/jfaf130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/10\/6\/1664\/64236972\/jfaf130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:20:58Z","timestamp":1762316458000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/10\/6\/1664\/8250675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,9,10]]},"published-print":{"date-parts":[[2025,11,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfaf130","relation":{},"ISSN":["2475-7241"],"issn-type":[{"value":"2475-7241","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,9,10]]}}}